|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.55 EUR | -1.29% |
|
-2.81% | -6.99% |
| 12-22 | China hits EU dairy with tariffs, broadening trade conflict | RE |
| 11-24 | Morgan Stanley raises Bridgepoint, cuts Ashmore | AN |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 6.95B | 7.35B | 8.77B | 8.02B | 6.93B | |||||
Total Revenues | 6.95B | 7.35B | 8.77B | 8.02B | 6.93B | |||||
Cost of Goods Sold, Total | 3.7B | 3.93B | 4.86B | 4.32B | 3.37B | |||||
Gross Profit | 3.26B | 3.42B | 3.91B | 3.7B | 3.56B | |||||
Selling General & Admin Expenses, Total | 2.25B | 2.35B | 2.68B | 2.54B | 2.36B | |||||
Provision for Bad Debts | 9.6M | 9.8M | 11.4M | 900K | 1.6M | |||||
Depreciation & Amortization - (IS) | 203M | 203M | 304M | 299M | 299M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 70.1M | 80.8M | - | - | - | |||||
Other Operating Expenses | - | - | - | - | - | |||||
Other Operating Expenses, Total | 2.54B | 2.64B | 3B | 2.84B | 2.66B | |||||
Operating Income | 721M | 780M | 912M | 858M | 897M | |||||
Interest Expense, Total | -72.6M | -69.5M | -73.9M | -75.2M | -89.7M | |||||
Interest And Investment Income | 200K | 300K | 6.6M | 21.8M | 34.8M | |||||
Net Interest Expenses | -72.4M | -69.2M | -67.3M | -53.4M | -54.9M | |||||
Income (Loss) On Equity Invest. | 1.6M | 3.9M | -400K | -1.9M | -900K | |||||
Currency Exchange Gains (Loss) | 2.2M | 8.6M | 900K | 11.2M | -6.7M | |||||
Other Non Operating Income (Expenses) | 2.5M | 1.9M | - | - | - | |||||
EBT, Excl. Unusual Items | 655M | 725M | 845M | 814M | 834M | |||||
Restructuring Charges | -4.4M | -33.3M | -62.8M | -57.6M | -43.3M | |||||
Merger & Related Restructuring Charges | -13.1M | -54.9M | -20.3M | -16.5M | -4.8M | |||||
Impairment of Goodwill | - | - | -3M | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | -1.9M | 180M | -56.8M | 98.2M | -6.3M | |||||
Asset Writedown | - | - | -3.3M | -15.3M | -1.4M | |||||
EBT, Incl. Unusual Items | 635M | 816M | 699M | 823M | 778M | |||||
Income Tax Expense | 81.2M | 53.3M | 92.5M | 94.5M | 105M | |||||
Earnings From Continuing Operations | 554M | 763M | 606M | 728M | 673M | |||||
Earnings Of Discontinued Operations | - | - | - | - | 61M | |||||
Net Income to Company | 554M | 763M | 606M | 728M | 734M | |||||
Minority Interest | - | - | -100K | 200K | - | |||||
Net Income - (IS) | 554M | 763M | 606M | 728M | 734M | |||||
Net Income to Common Incl Extra Items | 554M | 763M | 606M | 728M | 734M | |||||
Net Income to Common Excl. Extra Items | 554M | 763M | 606M | 728M | 673M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 3.13 | 4.31 | 3.42 | 4.11 | 4.25 | |||||
Basic EPS - Continuing Operations | 3.13 | 4.31 | 3.42 | 4.11 | 3.89 | |||||
Basic Weighted Average Shares Outstanding | 177M | 177M | 177M | 177M | 173M | |||||
Net EPS - Diluted | 3.12 | 4.3 | 3.41 | 4.1 | 4.24 | |||||
Diluted EPS - Continuing Operations | 3.12 | 4.3 | 3.41 | 4.1 | 3.89 | |||||
Diluted Weighted Average Shares Outstanding | 177M | 178M | 178M | 178M | 173M | |||||
Normalized Basic EPS | 2.31 | 2.56 | 2.98 | 2.87 | 3.01 | |||||
Normalized Diluted EPS | 2.31 | 2.55 | 2.97 | 2.86 | 3.01 | |||||
Dividend Per Share | 0.86 | 0.95 | 1.05 | 1.15 | 1.27 | |||||
Payout Ratio | 25.83 | 20.64 | 28.63 | 26.27 | 27.94 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 929M | 996M | 1.15B | 1.09B | 1.15B | |||||
EBITA | 762M | 826M | 963M | 910M | 955M | |||||
EBIT | 721M | 780M | 912M | 858M | 897M | |||||
EBITDAR | 932M | 998M | 1.16B | 1.1B | 1.15B | |||||
Effective Tax Rate - (Ratio) | 12.78 | 6.53 | 13.23 | 11.49 | 13.49 | |||||
Total Current Taxes | 78.2M | 75.3M | 124M | 128M | 108M | |||||
Total Deferred Taxes | 3M | -22M | -31.8M | -33.1M | -900K | |||||
Normalized Net Income | 409M | 453M | 528M | 509M | 521M | |||||
Interest on Long-Term Debt | 5.9M | 4.4M | 3.4M | 2.6M | 3.8M | |||||
Non-Cash Pension Expense | -12.8M | -4M | -3.1M | -5.1M | -2.8M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 282M | 297M | 303M | 301M | 310M | |||||
Net Rental Expense, Total | 2.3M | 2.2M | 3.9M | 3.9M | 4M | |||||
Imputed Operating Lease Interest Expense | 509K | 423K | 718K | 813K | 944K | |||||
Imputed Operating Lease Depreciation | 1.79M | 1.78M | 3.18M | 3.09M | 3.06M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 12.5M | 17.2M | 22.9M | 21.6M | 39.8M | |||||
Total Stock-Based Compensation | 12.5M | 17.2M | 22.9M | 21.6M | 39.8M |
- Stock Market
- Equities
- KRZ Stock
- Financials Kerry Group plc
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















